Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Mainehealth currently has 3 pending office actions within its company patent portfolio. These actions are located in the Biotechnology & Pharmaceuticals technology area. The prosecution of these matters involves 3 distinct examiners and 3 distinct art units. This distribution suggests that the portfolio covers several different technical sub-categories within the biotechnology field.
POLLOCK, ZACHARY JOSEPH is the busiest examiner for this company, with 1 pending office action. Although POLLOCK, ZACHARY JOSEPH is the busiest, the 3 distinct examiners across the portfolio mean that every pending application is being reviewed by a different individual. This requires the company to manage multiple examiner relationships simultaneously.
The 3 distinct art units indicate that the 3 pending office actions are distributed across different specialized groups at the USPTO. With only 1 pending office action assigned to the busiest examiner, no single individual dominates the prosecution of the entire portfolio. Practitioners should prepare for diverse feedback across the 3 distinct examiners currently assigned to these cases.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POLLOCK, ZACHARY JOSEPH | 1 | 26.5% | +39.6% |
| BORGEEST, CHRISTINA M | 1 | 55.7% | +21.4% |
| VAN BUREN, LAUREN K | 1 | 40.0% | +58.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18728689 | SYSTEMS, METHODS, AND MEDIA FOR SIMULATING INTERACTIONS WITH AN INFANT | POLLOCK, ZACHARY JOSEPH | — |
| 18633864 | COMPOSITIONS AND METHODS FOR AN ANTIBODY DRUG CONJUGATE DIRECTED TO A NON-CELL SURFACE THERAPEUTIC TARGET | BORGEEST, CHRISTINA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18728689 | SYSTEMS, METHODS, AND MEDIA FOR SIMULATING INTERACTIONS WITH AN INFANT | POLLOCK, ZACHARY JOSEPH | — |
| 18633864 | COMPOSITIONS AND METHODS FOR AN ANTIBODY DRUG CONJUGATE DIRECTED TO A NON-CELL SURFACE THERAPEUTIC TARGET | BORGEEST, CHRISTINA M | — |
| 17248217 | METHODS FOR TREATING CARDIAC INJURY | VAN BUREN, LAUREN K | — |
| Art Unit | Apps |
|---|---|
| 3715 | 1 |
| 1645 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18728689 | SYSTEMS, METHODS, AND MEDIA FOR SIMULATING INTERACTIONS WITH AN INFANT | POLLOCK, ZACHARY JOSEPH | 3715 | §103§112 | Final Rejection | — | Pending | Jul 12, 2024 |
| 18633864 | COMPOSITIONS AND METHODS FOR AN ANTIBODY DRUG CONJUGATE DIRECTED TO A NON-CELL SURFACE THERAPEUTIC TARGET | BORGEEST, CHRISTINA M | 1645 | §102§103§112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 17248217 | METHODS FOR TREATING CARDIAC INJURY | VAN BUREN, LAUREN K | 1657 | §112 | Non-Final OA | — | Pending | Jan 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMainehealth has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Zachary Joseph Pollock has the most, with 1 of Mainehealth's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
